CALL FOR SCIENCE SOLACI-CACI 2021 | New Deadline

New deadline: February 28th, 2021.

As we have already informed, due to the uncertainty generated by the current global health situation, the SOLACI CACI Congress scheduled for February 2021, will be held on August 4 thru 6, 2021 at Buenos Aires Hilton Hotel, in Argentina.

For this reason, the Scientific Committee has decided to extend the reception of new works once again, until February 28th, 2021.

In addition, the +350 works that we have already received were reopened to be edited, so that their authors have the opportunity to update and improve them, if they consider it necessary.

The Call for Science system will be enabled UNTIL FEBRUARY 28th 2021 on our official site.

More information

If you have questions or queries write to cientifico@solaci.org


Reasons to be part of the SOLACI-CACI 2021

  • Opportunity: This year, our annual meeting is offering a unique opportunity: the best works will be considered and assesed for publication in Catheterization and Cardiovascular Interventions (CCI) and Journal of Invasive Cardiology (JIC), two prestigious international PubMed Journals.
  • Professional Development: You shall be sharing your knowledge in the largest and most relevant meeting of interventional cardiologists in Latin America.
  • Networking and International Positioning: The best hemodynamics experts in Latin America have chosen this year to go to SOLACI Congress. Make good use of this opportunity to build fruitful relationships, learn, and share your ideas in a fraternal environment of academic excellence.

Cuenta Regresiva de trabajos

MORE INFORMATION ON THE CONGRESS

SOLACI-CACI 2020 Congress Postponed

Highlights

11th Edition of the ProEducar Fellows Course

Opportunities for the Industry

Venue | discover Buenos Aires Hilton Hotel

 


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Watch Again: Pulmonary Embolism in 2025 — Risk Stratification and Novel Therapeutic Approaches

Our webinar “Pulmonary Embolism in 2025: Risk Stratification and Novel Therapeutic Approaches” is now available to watch. The session took place on November 25,...

Watch Again: SELUTION – Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives

Our webinar “SELUTION: Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives”, held on November 19, 2025 via Zoom with...

25/11 – SOLACI Webinar: Pulmonary Embolism in 2025 – Risk Stratification and Novel Therapeutic Approaches

The Latin American Society of Interventional Cardiology invites you to participate in a new virtual scientific event titled “Pulmonary Embolism (PE) in 2025: Risk...

SELUTION Sirolimus-Eluting Balloon For De Novo Coronary Lesions – New Evidence and Clinical Perspectives

The Latin American Society of Interventional Cardiology invites you to join a new virtual scientific event focused on the latest evidence and clinical perspectives...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Coronary Perforations and Use of Covered Stents: Safe and Effective Long-Term Strategy?

Coronary perforations remain one of the most serious complications of percutaneous coronary intervention (PCI), especially in cases of Ellis ruptures type III. In these...

Is it really necessary to monitor all patients after TAVR?

Conduction disorders (CD) after transcatheter aortic valve replacement (TAVR) are a frequent complication and may lead to the need for permanent pacemaker implantation (PPI)....

Is it really necessary to monitor all patients after TAVR?

Conduction disorders (CD) after transcatheter aortic valve replacement (TAVR) are a frequent complication and may lead to the need for permanent pacemaker implantation (PPI)....